טוען...
Native Platelet Aggregation and Response to Aspirin in Persons With the Metabolic Syndrome and Its Components
BACKGROUND: Aspirin chemoprophylaxis for coronary artery disease (CAD) is recommended for persons with the metabolic syndrome. We determined the extent to which persons with increased risk for CAD with and without the metabolic syndrome accrued antiplatelet benefits from aspirin therapy. METHODS: We...
שמור ב:
| Main Authors: | , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Mary Ann Liebert, Inc.
2009
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3135890/ https://ncbi.nlm.nih.gov/pubmed/19351291 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/met.2008.0083 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|